Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Seed Redefines Daily Supplementation With the Launch of Co-Biotics -- A New Category of Targeted Innovations for the Body and Microbiome

Seed

News provided by

Seed Health

Sep 30, 2025, 08:00 ET

Share this article

Share toX

Share this article

Share toX

The launch taps into the transformative potential of the microbiome for daily nutrition, energy, and sleep, expanding Seed's portfolio beyond its award-winning probiotics

LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- Seed, a microbiome science company, today introduced Co-Biotics—a new category of daily supplements for the human body and its microbiome. Co-Biotics reflect an understanding of the microbiome's critical role in nearly every biological process, targeting both human and microbial pathways to maximize the benefits of daily supplementation. Seed's first three Co-Biotic formulations—DM-02™ Daily Multivitamin, AM-02™ Energy + Focus, and PM-02™ Sleep + Restore—are engineered to support the interconnected systems underpinning nutrient metabolism, cognitive performance, and circadian rhythms.

Continue Reading
Seed's new Co-Biotic Innovations: DM-02™ Daily Multivitamin, AM-02™ Energy + Focus, PM-02™ Sleep + Restore
Seed's new Co-Biotic Innovations: DM-02™ Daily Multivitamin, AM-02™ Energy + Focus, PM-02™ Sleep + Restore

The launch marks a pivotal evolution in Seed's portfolio as the company expands beyond probiotics to bring microbiome innovation to new categories of daily health.

"Since its founding, Seed has pioneered new frontiers in applying microbiome science to human health," said Cathrin Bowtell, Chief Executive Officer of Seed Health. "With Co-Biotics, we're creating a new category in daily supplementation—grounded in science and shaped by the voices of our global community, who continue to seek more ways our approach to the microbiome can support their health."

A Novel, Microbiome-Driven Approach to Nutrition, Energy, and Sleep

While most supplementation is designed for human biology alone, Seed's Co-Biotics each contain two complementary formulations—one for the human body and one for the microbiome—housed together in the company's proprietary ViaCap® system. This capsule-in-capsule technology separates ingredients into two precise release phases so each reaches its intended site of action:

  • Outer capsule, for the human body: Delivers bioavailable vitamins, minerals, and clinically studied compounds for uptake in the upper gastrointestinal (GI) tract, where they can be efficiently absorbed and utilized to meet core physiological needs.
  • Inner capsule, for the microbiome: Engineered to transport prebiotics, postbiotics, and other microbially accessible nutrients in the colon—home to the majority of the gut microbiome—where they can support microbial activity and downstream functions linked to long-term health.

"For decades, supplementation has focused solely on the human body, overlooking the microbiome's role in regulating key health functions," said Zain Kassam, M.D., M.P.H., Chief Medical Officer of Seed Health. "In the last decade, science has shown that this influence spans systems as varied as nutrient metabolism, brain signaling, and sleep. Co-Biotics apply this science—working with both human and microbial systems to deliver more holistic health support."

The Innovations

  • DM-02™ Daily Multivitamin • A next-generation multivitamin formulated to support the nutritional needs of both the body and the microbiome, with 100% of the Daily Value of 20 essential vitamins and minerals in bioavailable and bioactive forms.

    The microbiome plays a critical role in how the body absorbs, metabolizes, and produces nutrients—yet most multivitamins are absorbed too early in the digestive tract, starving these microbes of the nutrients they need to function optimally. DM-02™ solves for this with a dual-focus formulation: the outer capsule is formulated with health-critical vitamins and minerals to address common nutritional gaps, released in the upper GI tract for optimal absorption by the body. The inner capsule delivers prebiotics, postbiotics, and microbiome-accessible nutrients to the colon, where gut microbes can use them as fuel to perform essential functions vital to daily physiological balance.

    Together, the human- and microbiome-targeted formulations in DM-02™ deliver comprehensive daily support—promoting overall health and longevity, immune function, bone health, and visible markers like hair, skin, and nails.
  • AM-02™ Energy + Focus • A caffeine-free daily formulation developed to support sustained energy, sharpen focus, and enhance cognitive performance—without the overstimulation or crash of traditional energy products. AM-02™ targets the gut-brain axis to promote resilient, sustained energy and focus.

    While most energy products rely on stimulants like caffeine, which can spike cortisol and overtax the nervous system, AM-02™ is formulated with clinically studied compounds, including theacrine, methylliberine, and ginseng root, to promote mental clarity and alertness with a steadier, more sustained effect. The outer capsule delivers fast-acting nootropics with a multi-peak energy profile, for a steady, sustained effect throughout the day. Meanwhile, the inner capsule supports the gut-brain axis with B vitamins, prebiotics, and postbiotics, while also delivering cofactors to fuel mitochondrial function and cellular energy production.

    With consistent use, AM-02™ provides compounding benefits—supporting stress resilience, enhancing focus and attention, and helping the body maintain balanced energy in the long term.
  • PM-02™ Sleep + Restore • A non-habit-forming nightly sleep supplement that works across human and microbial pathways to support circadian rhythm regulation, ease nighttime stress, and promote deeper overnight restoration. Unlike traditional sleep aids that blunt circadian rhythms with sedatives or excessive melatonin, PM-02™ reinforces the body's natural sleep-wake cycle for more restorative, long-term sleep health—without next-day haze.

    The outer capsule delivers sleep-supportive compounds—including a dual-phase, bioidentical dose of melatonin that mirrors the body's natural release pattern—alongside microbially produced GABA and clinically studied ashwagandha for calm, sustained rest. The inner capsule delivers prebiotics, postbiotics, and cofactors to the microbiome, which plays a crucial role in biological processes linked to circadian rhythms, overnight renewal, and long-term resilience.

    Plus, PM-02™ benefits build over time—delivering immediate support for falling asleep and staying asleep, while progressively balancing melatonin and cortisol levels to help recalibrate circadian rhythms for lasting sleep health.

"With DS-01®, we set a new standard in probiotics," said Ara Katz, Co-founder of Seed Health. "With Co-Biotics, we're bringing microbiome science into more aspects of daily life to transform how people support their bodies and the trillions of microbes that sustain them."

Where to Purchase

All three products are now available direct-to-consumer at Seed.com and Amazon, with nationwide retail launches at Target on October 11 and Sprouts on November 3.

For more information, visit seed.com/new-products.

About Seed Health
Seed Health is a microbiome science company pioneering clinically validated innovations for gut and whole-body health. Rooted in rigorous research and peer-reviewed studies, Seed is setting new standards for efficacy, safety, and trust in the biotics category. Our flagship innovation, DS-01® Daily Synbiotic, is a pre- and probiotic studied in multiple human clinical trials and trusted by over one million people for its systemic benefits, including gut, skin, immune, and heart health. Our pipeline of gut-directed innovations, developed in collaboration with world-renowned researchers and clinicians, harnesses the microbiome as a driver of longevity, systemic health, and daily well-being. Grounded in the ethos that human and planetary health are interconnected, our environmental research division, SeedLabs, advances microbial interventions to enhance biodiversity and help restore ecosystems impacted by human activity.

Press Contact
[email protected]

SOURCE Seed Health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

As Coral Reefs Vanish, Scientists Are Turning to Aquariums for Help

As Coral Reefs Vanish, Scientists Are Turning to Aquariums for Help

The next breakthrough in coral conservation could be hiding in your aquarium. Seed Health and The Two Frontiers Project (2FP), with support from...

Leading Gut Health Company Seed Expands Retail Footprint with Nationwide Launch at Sprouts Farmers Market

Leading Gut Health Company Seed Expands Retail Footprint with Nationwide Launch at Sprouts Farmers Market

Seed, a microbiome science company, today announced the nationwide retail launch of its clinically validated microbiome innovations at Sprouts...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Supplementary Medicine

Supplementary Medicine

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.